Company Name:uniQure N.V.
CEO: Matthew C. Kapusta

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: uniQure NV is engaged in the field of gene therapy platform across three therapeutic focus areas: Liver/Metabolic Disease, Central Nervous System (CNS) Disease and Cardiovascular Disease.


Key numbers

Market Capitalization:2259780114
Shares Outstanding: 42742200
Float: 32839772.588400003
Next Earning Date:2020-03-11
TTm EPS: -2.7326
TTm Dividend Rate:
200 days moving average:56.68
50 days moving average: 46.18
One day percent Change: 6.96



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,